We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.
- Authors
Chiron, C; Marchand, M C; Tran, A; Rey, E; d'Athis, P; Vincent, J; Dulac, O; Pons, G
- Abstract
Stiripentol is an inhibitor of cytochrome P450 that showed antiepileptic efficacy in severe myoclonic epilepsy in infancy (SMEI) in association with clobazam and valproate in an open study. To confirm these results, 41 children with SMEI were included in a randomised, placebo-controlled, add-on trial.
- Publication
Lancet (London, England), 2000, Vol 356, Issue 9242, p1638
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(00)03157-3